The current pilot data, along with the weight loss findings from the main phase two trial, further support the use of retatrutide in people with NASH. Julio Rosenstock, MD, Principal Investigator and Director of Velocity Clinical Research at Medical City and Clinical Professor of Medicine at the University of Texas (UT) Southwestern, discussed the efficacy and safety results from the Retatrutide for People with Type 2 Diabetes Phase 2 Study
If your goal is to build lasting habits and maintain results long term, Noom offers a more comprehensive framework that extends beyond the prescriptioncombining GLP-1 treatment with education, coaching, and structured behavioral support
Lower blood sugar through enhanced insulin secretion
It's not a place to click and hope
Semaglutide GLP-1 injections are a type of medication that falls under the class of glucagon-like peptide-1 (GLP-1) receptor agonists
Improving long term adherence therefore becomes both a clinical and commercial imperative in an increasingly competitive market